Prevention and treatment of necrotising enterocolitis in preterm neonates

Area of Science:

• Neonatology
• Pediatric Gastroenterology
• Critical Care Medicine

Background:

• Necrotizing enterocolitis (NEC) poses significant mortality and morbidity risks, particularly in preterm infants.
• The increasing number of preterm survivors necessitates advanced strategies for NEC prevention and treatment.
• Current research focuses on novel interventions and re-evaluating established practices.

Purpose of the Study:

• To review current and emerging strategies for the prevention and treatment of NEC in preterm infants.
• To highlight the need for further research into the safety and efficacy of various interventions.
• To emphasize the importance of a comprehensive approach to NEC management.

Main Methods:

• Review of existing literature on NEC prevention and treatment strategies.
• Discussion of promising interventions such as probiotic supplementation and immunomodulating agents.
• Analysis of established practices including antenatal glucocorticoid therapy and breast milk feeding.
• Identification of areas requiring further clinical research, such as ileus of prematurity and feeding protocols.

Main Results:

• Probiotic supplementation is a promising option for NEC prevention, but requires further large-scale trials to assess safety (sepsis, neurodevelopmental, immune function).
• Established strategies like antenatal glucocorticoids and breast milk remain crucial.
• Further research is needed on feeding minimal enteral feeds, standardized regimens, and the association of practices like red cell transfusions, H2 receptor blockade, and feed thickening with NEC.

Conclusions:

• A multifaceted approach combining novel therapies with proven strategies is essential for NEC prevention and treatment.
• Continued research is vital to optimize the safety and efficacy of interventions for preterm infants at risk of NEC.
• A package of best practices offers the most appropriate strategy for managing NEC.